Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W; Schizophrenia Patient Outcomes Research Team (PORT).

Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2. Review.

2.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD.

J Psychiatr Pract. 2005 Sep;11(5):315-39. Review.

5.

[Associated psychotropic drugs in deficit schizophrenia].

Beaufils B.

Encephale. 1996 Jun;22 Spec No 2:41-3. Review. French.

PMID:
8767041
6.

[New psychopharmacologic alternatives in treatment of schizophrenia].

Bryois C.

Schweiz Arch Neurol Psychiatr (1985). 1994;145(6):19-24. Review. French.

PMID:
7533941
7.

Evidence-based pharmacotherapy of schizophrenia.

Emsley R, Oosthuizen P.

Int J Neuropsychopharmacol. 2004 Jun;7(2):219-38. Epub 2004 Apr 13. Review.

PMID:
15043765
8.

Lithium for schizophrenia.

Leucht S, Helfer B, Dold M, Kissling W, McGrath JJ.

Cochrane Database Syst Rev. 2015 Oct 28;(10):CD003834. doi: 10.1002/14651858.CD003834.pub3. Review.

PMID:
26509923
9.

Treatment of schizoaffective disorder and schizophrenia with mood symptoms.

Levinson DF, Umapathy C, Musthaq M.

Am J Psychiatry. 1999 Aug;156(8):1138-48. Review.

PMID:
10450252
10.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ; WFSBP Task Force on Treatment Guidelines for Schizophrenia.

World J Biol Psychiatry. 2005;6(3):132-91. Review.

PMID:
16173147
11.

Drug treatment of schizophrenia. Overview of recent research.

Marder SR, Wirshing WC, Van Putten T.

Schizophr Res. 1991 Mar-Apr;4(2):81-90. Review.

PMID:
1674883
12.

Acupuncture for schizophrenia.

Shen X, Xia J, Adams CE.

Cochrane Database Syst Rev. 2014 Oct 20;(10):CD005475. doi: 10.1002/14651858.CD005475.pub2. Review.

PMID:
25330045
13.

Treatment of non-schizophrenic disorders: focus on atypical antipsychotics.

Jeste DV, Dolder CR.

J Psychiatr Res. 2004 Jan;38(1):73-103. Review.

PMID:
14690772
14.

Psychopharmacologic treatment of negative schizophrenic symptoms.

Opler LA, Albert D, Ramirez PM.

Compr Psychiatry. 1994 Jan-Feb;35(1):16-28. Review.

PMID:
7908618
15.

Pharmacological treatment of negative symptoms in schizophrenia.

Möller HJ, Czobor P.

Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):567-78. doi: 10.1007/s00406-015-0596-y. Epub 2015 Apr 21. Review.

PMID:
25895634
16.

Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials.

Leucht S, Kissling W, McGrath J.

J Clin Psychiatry. 2004 Feb;65(2):177-86. Review.

PMID:
15003070
17.

Management of treatment resistant schizophrenia unresponsive to clozapine.

Barnes TR, McEvedy CJ, Nelson HE.

Br J Psychiatry Suppl. 1996 Dec;(31):31-40. Review. No abstract available.

PMID:
8968653
18.

The Mount Sinai conference on the pharmacotherapy of schizophrenia.

Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, Lieberman J, Schooler NR.

Schizophr Bull. 2002;28(1):5-16. Review.

PMID:
12047022
19.

Determinants of medication compliance in schizophrenia: empirical and clinical findings.

Fenton WS, Blyler CR, Heinssen RK.

Schizophr Bull. 1997;23(4):637-51. Review.

PMID:
9366000
20.

Good medical practice in antipsychotic pharmacotherapy.

Peuskens J.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S35-41. Review.

PMID:
9690969

Supplemental Content

Support Center